Astrocyte activation in the periaqueductal gray promotes descending facilitation to cancer-induced bone pain through the JNK MAPK signaling pathway

Mol Pain. 2019 Jan-Dec:15:1744806919831909. doi: 10.1177/1744806919831909.

Abstract

Descending nociceptive modulation from the supraspinal structures has an important role in cancer-induced bone pain (CIBP). Midbrain ventrolateral periaqueductal gray (vlPAG) is a critical component of descending nociceptive circuits; nevertheless, its precise cellular and molecular mechanisms involved in descending facilitation remain elusive. Our previous study has shown that the activation of p38 MAPK in vlPAG microglia is essential for the neuropathic pain sensitization. However, the existence of potential connection between astrocytes and c-Jun N-terminal kinase (JNK) pathway in CIBP has not yet been elucidated. The following study examines the involvement of astrocyte activation and upregulation of p-JNK in vlPAG, using a CIBP rat model. Briefly, CIBP was mimicked by an intramedullary injection of Walker 256 mammary gland carcinoma cells into the animal tibia. A significant increase in expression levels of astrocytes in the vlPAG of CIBP rats was observed. Furthermore, stereotaxic microinjection of the astrocytic cytotoxin L-α-aminoadipic acid decreased the mechanical allodynia as well as established and reversed the astrocyte activation in CIBP rats. A significant increase in expression levels of p-JNK in astrocytes in vlPAG of CIBP rats was also observed. Moreover, the intrathecal administration of JNK inhibitors SP600125 reduced the expression of glial fibrillary acidic protein, while microinjection of the SP600125 decreased the mechanical allodynia of CIBP rats. These results suggested that CIBP is associated with astrocyte activation in the vlPAG that probably participates in driving descending pain facilitation through the JNK MAPK signaling pathway. To sum up, these findings reveal a novel site of astrocytes modulation of CIBP.

Keywords: Cancer-induced bone pain; astrocyte; c-Jun N-terminal kinase; descending facilitation; hyperalgesia; periaqueductal gray.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthracenes / pharmacology
  • Astrocytes / pathology*
  • Body Weight / drug effects
  • Bone Neoplasms / complications
  • Bone Neoplasms / pathology
  • CD11b Antigen / metabolism
  • Cancer Pain / etiology
  • Cancer Pain / pathology*
  • Carcinoma / complications
  • Carcinoma / pathology
  • Cell Line, Tumor
  • Enzyme Inhibitors / pharmacology
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Expression Regulation, Neoplastic / physiology*
  • Glial Fibrillary Acidic Protein / metabolism
  • Hyperalgesia / etiology
  • MAP Kinase Kinase 4 / metabolism*
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology*
  • Periaqueductal Gray / metabolism
  • Periaqueductal Gray / pathology*
  • Phosphopyruvate Hydratase / metabolism
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Anthracenes
  • CD11b Antigen
  • Enzyme Inhibitors
  • Glial Fibrillary Acidic Protein
  • ITGAM protein, human
  • pyrazolanthrone
  • MAP Kinase Kinase 4
  • Phosphopyruvate Hydratase